{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:48Z","timestamp":1793060028921,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Axillary osmidrosis (AO) is a strong, unpleasant odor that originates from the apocrine axillary glands. Treatments of AO include surgical treatment and nonsurgical treatment. The surgical procedure yields effective results with a low recurrence rate but requires a longer recovery time and has more postoperative complications. Nonsurgical treatments are minimally invasive and safe, but short-term recurrence may occur in some cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>Polidocanol sclerotherapy was first described for management of AO. This retrospective study explored the clinical efficacy in relieving symptom of AO assessed by AO severity using the axillary osmidrosis grading system and safety of polidocanol sclerotherapy in treating AO.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS AND METHODS<\/jats:title>\n            <jats:p>This retrospective study included 25 patients with AO single-site study, with 12 patients receiving polidocanol (1%) sclerotherapy (the polidocanol group) and 13 receiving botulinum toxin A (BTX-A) injection (the BTX-A group). The short-term efficacy (7 days after injection), the long-term efficacy (6 months after injection), the recurrence rate, and complications were compared between the 2 groups. A <jats:italic toggle=\"yes\">p-<\/jats:italic>value of &lt;0.05 was considered statistically significant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>The short-term efficacies of polidocanol sclerotherapy and BTX-A injection were 100% and 69.2%, which was not clinically significant (<jats:italic toggle=\"yes\">p<\/jats:italic> &gt; .05), whereas their long-term efficacies were 100% and 46.2%, respectively (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .05). The recurrence rates in the polidocanol and BTX-A groups were 25.0% and 84.6%, respectively (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .05). The complications did not differ significantly between the 2 groups (<jats:italic toggle=\"yes\">p<\/jats:italic> &gt; .05). Although the short-term efficacy and complications were comparable between the 2 groups, the long-term efficacy of polidocanol sclerotherapy was superior to BTX-A injection. The polidocanol group has a lower recurrence rate than the BTX-A group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Polidocanol sclerotherapy may provide an effective and safe treatment with longer efficacy compared to toxin, which is an effective and safe option for AO treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004428","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T18:00:17Z","timestamp":1731952817000},"page":"290-295","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The Initial Exploration of Polidocanol Sclerotherapy for the Treatment of Axillary Osmidrosis: A Retrospective Study"],"prefix":"10.1097","volume":"51","author":[{"given":"Sunyuan","family":"Yao","sequence":"first","affiliation":[{"name":"All authors are affiliated with the Department of General Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantao","family":"Cai","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Department of General Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfang","family":"Zhu","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Department of General Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"R1-20250228","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-4632.2008.03735.x","article-title":"Etiology and management of axillary bromidrosis: a brief review","volume":"47","author":"Mao","year":"2008","journal-title":"Int J Dermatol"},{"key":"R2-20250228","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/SAP.0000000000002111","article-title":"Axillary osmidrosis: past, present, and future","volume":"84","author":"Morioka","year":"2020","journal-title":"Ann Plast Surg"},{"key":"R3-20250228","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1524-4725.1997.tb00036.x","article-title":"Carbon dioxide laser treatment vs subcutaneous resection of axillary osmidrosis","volume":"23","author":"Park","year":"1997","journal-title":"Dermatol Surg"},{"key":"R4-20250228","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/jdv.13219","article-title":"Treatment of axillary osmidrosis: a comparison between subcutaneous laser and superficial liposuction curettage","volume":"29","author":"Chen","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R5-20250228","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archsurg.136.10.1115","article-title":"Experiences in thoracoscopic sympathectomy for axillary hyperhidrosis and osmidrosis: focusing on the extent of sympathectomy","volume":"136","author":"Hsu","year":"2001","journal-title":"Arch Surg"},{"key":"R6-20250228","first-page":"531","article-title":"Hyperhidrosis of the axillae. A method of surgical treatment, Acta Chir","volume":"124","author":"Skoog","year":"1962","journal-title":"Scand."},{"key":"R7-20250228","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/1346-8138.12230","article-title":"Local injection of botulinum toxin A: an alternative therapy for axillary osmidrosis","volume":"41","author":"Xie","year":"2014","journal-title":"J Dermatol"},{"key":"R8-20250228","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/ced.12020","article-title":"Percutaneous ethanol injection for the treatment of axillary osmidrosis","volume":"38","author":"Han","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"R9-20250228","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/ijdvl.IJDVL_704_16","article-title":"Percutaneous ethanol injection as a promising and minimally invasive treatment for axillary osmidrosis: double-blinded randomized controlled trial","volume":"84","author":"Asilian","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R10-20250228","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.thorsurg.2016.06.003","article-title":"Emerging nonsurgical treatments for hyperhidrosis","volume":"26","author":"Kurta","year":"2016","journal-title":"Thorac Surg Clin"},{"key":"R11-20250228","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/SAP.0000000000000911","article-title":"Osmidrosis treatment approaches: a systematic review and meta-analysis","volume":"78","author":"Shin","year":"2017","journal-title":"Ann Plast Surg"},{"key":"R12-20250228","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/09546634.2017.1329512","article-title":"A low initial botulinum toxin A treatment response does not predict poor long-term outcomes in patients with axillary bromhidrosis","volume":"29","author":"He","year":"2018","journal-title":"J Dermatol Treat"},{"key":"R13-20250228","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/jdv.18639","article-title":"Skin hyperpigmentation after sclerotherapy with polidocanol: a systematic review","volume":"37","author":"Bossart","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R14-20250228","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000637-200109000-00014","article-title":"What is the best method for treating osmidrosis?","volume":"47","author":"Park","year":"2001","journal-title":"Ann Plast Surg"},{"key":"R15-20250228","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.12659\/MSM.913932","article-title":"The treatment of axillary odor: a network meta-analysis","volume":"25","author":"Sun","year":"2019","journal-title":"Med Sci Monit"},{"key":"R16-20250228","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2230.1996.tb00093.x","article-title":"Botulinum toxin--a possible new treatment for axillary hyperhidrosis","volume":"21","author":"Bushara","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"R17-20250228","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.anplas.2014.11.006","article-title":"Axillary hyperhidrosis, botulinium A toxin treatment: review [in French]","volume":"61","author":"Clerico","year":"2016","journal-title":"Ann Chir Plast Esth\u00e9t"},{"key":"R18-20250228","first-page":"729","article-title":"Hyperhidrosis: management options","volume":"97","author":"McConaghy","year":"2018","journal-title":"Am Fam Physician"},{"key":"R19-20250228","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clindermatol.2003.12.029","article-title":"Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis","volume":"22","author":"Kreyden","year":"2004","journal-title":"Clin Dermatol"},{"key":"R20-20250228","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/09546634.2011.594869","article-title":"A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with botulinum toxin A","volume":"23","author":"He","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"R21-20250228","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.bjps.2017.06.037","article-title":"Effectiveness of botulinum toxin A injection for the treatment of secondary axillary bromhidrosis","volume":"70","author":"He","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R22-20250228","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00266-018-1075-4","article-title":"Long-term safety and efficacy of botulinum toxin A treatment in adolescent patients with axillary bromhidrosis","volume":"42","author":"Wang","year":"2018","journal-title":"Aesthet Plast Surg"},{"key":"R23-20250228","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000479433","article-title":"Histopathological evidence of the efficacy of percutaneous ethanol injection in the treatment of axillary osmidrosis: a promising new procedure","volume":"4","author":"Asilian","year":"2018","journal-title":"Skin Appendage Disord"},{"key":"R24-20250228","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/0268355514534648","article-title":"Interaction of detergent sclerosants with cell membranes","volume":"30","author":"Parsi","year":"2015","journal-title":"Phlebology"},{"key":"R25-20250228","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/DSS.0000000000003520","article-title":"Polidocanol: a review of off-label dermatologic uses","volume":"48","author":"Nguyen","year":"2022","journal-title":"Dermatol Surg"},{"key":"R26-20250228","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1080\/03007995.2017.1325732","article-title":"Efficacy and safety of ultrasound-guided percutaneous polidocanol sclerotherapy in benign predominantly cystic thyroid nodules: a prospective study","volume":"33","author":"Gong","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"R27-20250228","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10151-022-02609-w","article-title":"A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)","volume":"26","author":"Gallo","year":"2022","journal-title":"Tech Coloproctol"},{"key":"R28-20250228","doi-asserted-by":"crossref","first-page":"116","DOI":"10.14639\/0392-100X-N1310","article-title":"Sclerotherapy with polidocanol microfoam in head and neck venous and lymphatic malformations","volume":"42","author":"De Corso","year":"2022","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"R29-20250228","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00042728-200604000-00004","article-title":"Tumescent liposuction with dermal curettage for treatment of axillary osmidrosis and hyperhidrosis","volume":"32","author":"Lee","year":"2006","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:10:03Z","timestamp":1740748203000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004428","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]}}}